Onderneming Biosyent Inc. Toronto S.E.
Aandelen
RX
CA0906901081
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
96,9
%
| 27 | 96,5 % | 31 | 96,9 % | +13,61% |
Insecticide
3,1
%
| 1 | 3,5 % | 1 | 3,1 % | -0,21% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
95,9
%
| 27 | 96,7 % | 30 | 95,9 % | +12,16% |
Middle East
3,3
%
| 1 | 2,4 % | 1 | 3,3 % | +53,27% |
United States
0,8
%
| 0 | 0,8 % | 0 | 0,8 % | +7,49% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Goehrum
CEO | Chief Executive Officer | 64 | 01-01-96 |
Robert March
DFI | Director of Finance/CFO | - | 10-09-18 |
Navid Ashrafi
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-14 |
Neelu Atwal
HRO | Human Resources Officer | - | 01-01-19 |
Corporate Officer/Principal | - | 01-08-15 | |
Kevin Wilson
PRN | Corporate Officer/Principal | - | 01-03-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sara Elford
BRD | Director/Board Member | 53 | 08-01-18 |
René Goehrum
CEO | Chief Executive Officer | 64 | 01-01-96 |
Peter Lockhard
BRD | Director/Board Member | 60 | 01-06-02 |
Larry Andrews
BRD | Director/Board Member | 71 | 08-01-18 |
Joseph Arcuri
BRD | Director/Board Member | 58 | 29-05-18 |
Stephen Wilton
BRD | Director/Board Member | 63 | 16-01-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 967 052 | 7 257 346 ( 60,64 %) | 175 753 ( 1,469 %) | 60,64 % |
Bedrijfsgegevens
![Adres Biosyent Inc.(RX)](https://cdn.zonebourse.com/static/address/1411555.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,35% | 815 mld. | |
+32,33% | 597 mld. | |
-0,10% | 377 mld. | |
+15,47% | 319 mld. | |
+13,10% | 310 mld. | |
+16,13% | 247 mld. | |
+14,23% | 228 mld. | |
+16,54% | 180 mld. | |
+4,31% | 170 mld. |